Jpmorgan Chase & CO Bluebird Bio, Inc. Transaction History

Jpmorgan Chase & CO

$1.14 Trillion
Q2 2024

A detailed history of Jpmorgan Chase & CO transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 635,751 shares of BLUE stock, worth $292,445. This represents 0.0% of its overall portfolio holdings.

Number of Shares

635,751

Previous 1,933,076 67.11%

Holding current value

$292,445

Previous $2.47 Million 74.82%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$0.85 - $1.26 $1.1 Million - $1.63 Million	-1,297,325 Reduced 67.11%	635,751 $623,000
Q1 2024 May 10, 2024	BUY	$0.91 - $1.75 $161,289 - $310,171	177,241 Added 10.09%	1,933,076 $2.47 Million
Q4 2023 Feb 12, 2024	BUY	$1.32 - $4.83 $112,271 - $410,810	85,054 Added 5.09%	1,755,835 $2.42 Million
Q3 2023 Nov 14, 2023	SELL	$3.02 - $4.05 $282,490 - $378,837	-93,540 Reduced 5.3%	1,670,781 $5.08 Million
Q2 2023 Aug 11, 2023	BUY	$2.79 - $5.03 $1.45 Million - $2.61 Million	519,354 Added 41.72%	1,764,321 $5.8 Million
Q1 2023 May 18, 2023	BUY	$3.14 - $8.22 $247,928 - $649,034	78,958 Added 6.77%	1,244,967 $3.96 Million
Q1 2023 May 11, 2023	SELL	$3.14 - $8.22 $398,896 - $1.04 Million	-127,037 Reduced 9.82%	1,166,009 $3.71 Million
Q4 2022 Feb 13, 2023	BUY	$5.77 - $8.49 $381,835 - $561,834	66,176 Added 5.39%	1,293,046 $8.95 Million
Q3 2022 Nov 14, 2022	SELL	$3.75 - $7.39 $1.79 Million - $3.54 Million	-478,619 Reduced 28.06%	1,226,870 $7.77 Million
Q2 2022 Aug 11, 2022	SELL	$2.94 - $5.23 $467,589 - $831,800	-159,044 Reduced 8.53%	1,705,489 $7.06 Million
Q1 2022 May 11, 2022	SELL	$4.07 - $10.6 $1.43 Million - $3.72 Million	-351,377 Reduced 15.86%	1,864,533 $9.04 Million
Q4 2021 Feb 10, 2022	BUY	$8.96 - $16.31 $2.54 Million - $4.62 Million	283,213 Added 14.65%	2,215,910 $22.1 Million
Q3 2021 Nov 12, 2021	BUY	$11.24 - $21.0 $21.7 Million - $40.6 Million	1,932,697 New	1,932,697 $36.9 Million

Others Institutions Holding BLUE

# of Institutions

158

Shares Held

79.9M

Call Options Held

525K

Put Options Held

634K

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $35.5M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Bluebird Bio, Inc. Transaction History